Hagop M Kantarjian

Hagop M Kantarjian

UNVERIFIED PROFILE

Are you Hagop M Kantarjian?   Register this Author

Register author
Hagop M Kantarjian

Hagop M Kantarjian

Publications by authors named "Hagop M Kantarjian"

Are you Hagop M Kantarjian?   Register this Author

100Publications

2546Reads

5Profile Views

Reply to Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?

Cancer 2019 Nov 10;125(21):3891-3892. Epub 2019 Jul 10.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32385DOI Listing
November 2019

Philadelphia chromosome-negative acute leukemia in patients with chronic myeloid leukemia.

Am J Hematol 2019 Oct 28;94(10):E256-E259. Epub 2019 Jul 28.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25571DOI Listing
October 2019

Targeted therapy paves the way for the cure of acute lymphoblastic leukaemia.

Br J Haematol 2019 Sep 30. Epub 2019 Sep 30.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16207DOI Listing
September 2019

Treatment value of second-generation BCR-ABL1 tyrosine kinase inhibitors compared with imatinib to achieve treatment-free remission in patients with chronic myeloid leukaemia: a modelling study.

Lancet Haematol 2019 Aug 14;6(8):e398-e408. Epub 2019 Jun 14.

Department of Leukemia, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30087-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658341PMC
August 2019

SOHO State of the Art Update and Next Questions: Advances in the Treatment of Adult Acute Lymphoblastic Leukemia.

Clin Lymphoma Myeloma Leuk 2019 Aug 3;19(8):471-479. Epub 2019 Jul 3.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.06.011DOI Listing
August 2019

Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia.

Clin Epigenetics 2019 Jul 22;11(1):106. Epub 2019 Jul 22.

Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13148-019-0704-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647096PMC
July 2019

How much of US health care spending provides direct care or benefit to patients?

Cancer 2019 May 29;125(9):1404-1409. Epub 2019 Jan 29.

College of Medicine, University of South Alabama, Mobile, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31865DOI Listing
May 2019

Recent advances in the treatment of acute lymphoblastic leukemia.

Leuk Lymphoma 2019 May 16:1-16. Epub 2019 May 16.

b Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1605071DOI Listing
May 2019

Inotuzumab ozogamicin, a nonchemotherapy option for relapsed acute lymphoblastic leukemia.

Clin Adv Hematol Oncol 2019 May;17(5):268-270

The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
May 2019

Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.

N Engl J Med 2019 04;380(17):1628-1637

From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1815105DOI Listing
April 2019

Myeloid cell leukemia-1 dependence in acute myeloid leukemia: a novel approach to patient therapy.

Oncotarget 2019 Feb 8;10(12):1250-1265. Epub 2019 Feb 8.

The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26579DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383813PMC
February 2019

Prognostic significance of hyperdiploidy in adult acute myeloid leukemia.

Am J Hematol 2018 11 9;93(11):E357-E360. Epub 2018 Sep 9.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25240DOI Listing
November 2018

Reply to Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?

Cancer 2018 11 1;124(21):4261. Epub 2018 Oct 1.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31683
Publisher Site
http://dx.doi.org/10.1002/cncr.31683DOI Listing
November 2018

Toward the potential cure of leukemias in the next decade.

Cancer 2018 11 6;124(22):4301-4313. Epub 2018 Oct 6.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31669
Publisher Site
http://dx.doi.org/10.1002/cncr.31669DOI Listing
November 2018

The opioid epidemic in the United States-Overview, origins, and potential solutions.

Cancer 2018 11 9;124(22):4279-4286. Epub 2018 Oct 9.

Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31713
Publisher Site
http://dx.doi.org/10.1002/cncr.31713DOI Listing
November 2018

Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.

J Clin Oncol 2018 06 27;36(18):1788-1797. Epub 2018 Apr 27.

Kiyomi Morita, Hagop M. Kantarjian, Feng Wang, Yuanqing Yan, Carlos Bueso-Ramos, Koji Sasaki, Ghayas C. Issa, Sa Wang, Jeffrey Jorgensen, Xingzhi Song, Jianhua Zhang, Samantha Tippen, Rebecca Thornton, Marcus Coyle, Latasha Little, Curtis Gumbs, Naveen Pemmaraju, Naval Daver, Courtney D. DiNardo, Marina Konopleva, Michael Andreeff, Farhad Ravandi, Jorge E. Cortes, Tapan Kadia, Elias Jabbour, Guillermo Garcia-Manero, Keyur P. Patel, P. Andrew Futreal, and Koichi Takahash, The University of Texas MD Anderson Cancer Center, Houston, TX; Kiyomi Morita, The University of Tokyo, Tokyo; and Koichi Takahashi, Kyoto University, Kyoto, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.6757DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008108PMC
June 2018

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

N Engl J Med 2018 Jun 2;378(25):2386-2398. Epub 2018 Jun 2.

From the University of Texas M.D. Anderson Cancer Center, Houston (C.D.D., H.M.K.); Memorial Sloan Kettering Cancer Center (E.M.S., M.S.T.) and Weill Cornell Medical College (G.J.R.), New York; Institut Gustave Roussy, Villejuif (S.B., C.W.), and Centre Hospitalier Universitaire Bordeaux, Bordeaux (A.P.) - both in France; Northwestern University, Chicago (J.K.A.); Ohio State University Wexner Medical Center, Columbus (A.S.M.); Sylvester Comprehensive Cancer Center, University of Miami, Miami (R.S.); University of Texas Southwestern Medical Center, Dallas (R.H.C.); University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco (G.N.M.), and City of Hope Medical Center, Duarte (A.S.S.) - both in California; University of Colorado School of Medicine, Aurora (D.A.P.); Sarah Cannon Research Institute, Nashville (W.D.); Massachusetts General Hospital Cancer Center (A.T.F.) and Dana-Farber Cancer Institute (R.M.S.), Boston, and Agios Pharmaceuticals, Cambridge (S.C., H.W., V.Z., K.E.Y., S.M.K., H.Y., D.D., B.F., M.G., H.L., S.A., B.W., E.C.A.) - all in Massachusetts; University of Alabama at Birmingham, Birmingham (H.P.E.); Johns Hopkins University, Baltimore (G.T.P.); Washington University School of Medicine, St. Louis (G.L.U.); Mayo Clinic, Jacksonville, FL (J.M.F.); Oregon Health and Science University Knight Cancer Institute, Portland (E.T.); Hollings Cancer Center, Medical University of South Carolina, Charleston (R.K.S.); Winship Cancer Institute of Emory University, Atlanta (M.L.A.); Mayo Clinic, Phoenix, AZ (J.L.S.); and Cleveland Clinic, Cleveland (M.A.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1716984DOI Listing
June 2018

Patient-reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia.

Cancer 2018 05 6;124(10):2151-2160. Epub 2018 Mar 6.

Adult Bone Marrow Transplant Unit, University Hospitals Bristol, National Health Service Foundation Trust, Bristol, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31317DOI Listing
May 2018

Hepatitis C: When high drug prices preclude patient benefit.

Cancer 2018 04 27;124(8):1644-1646. Epub 2018 Feb 27.

Department of Clinical Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31292DOI Listing
April 2018

The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment.

CA Cancer J Clin 2018 03 16;68(2):153-165. Epub 2018 Jan 16.

Medical Oncologist, Immigrant Health and Cancer Disparities Service, Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652174PMC
March 2018

Outcomes of Patients With Relapsed Core Binding Factor-Positive Acute Myeloid Leukemia.

Clin Lymphoma Myeloma Leuk 2018 01 25;18(1):e19-e25. Epub 2017 Sep 25.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.09.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861376PMC
January 2018

Therapy-related myelofibrosis does not appear to exist.

Blood Adv 2017 Jun 26;1(14):863-866. Epub 2017 May 26.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2017007369DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737601PMC
June 2017